259 related articles for article (PubMed ID: 20412587)
1. PI3Kp110-, Src-, FAK-dependent and DOCK2-independent migration and invasion of CXCL13-stimulated prostate cancer cells.
El Haibi CP; Sharma PK; Singh R; Johnson PR; Suttles J; Singh S; Lillard JW
Mol Cancer; 2010 Apr; 9():85. PubMed ID: 20412587
[TBL] [Abstract][Full Text] [Related]
2. CXCL13 mediates prostate cancer cell proliferation through JNK signalling and invasion through ERK activation.
El-Haibi CP; Singh R; Sharma PK; Singh S; Lillard JW
Cell Prolif; 2011 Aug; 44(4):311-9. PubMed ID: 21645150
[TBL] [Abstract][Full Text] [Related]
3. Differential G protein subunit expression by prostate cancer cells and their interaction with CXCR5.
El-Haibi CP; Sharma P; Singh R; Gupta P; Taub DD; Singh S; Lillard JW
Mol Cancer; 2013 Jun; 12():64. PubMed ID: 23773523
[TBL] [Abstract][Full Text] [Related]
4. Clinical and biological significance of CXCR5 expressed by prostate cancer specimens and cell lines.
Singh S; Singh R; Singh UP; Rai SN; Novakovic KR; Chung LW; Didier PJ; Grizzle WE; Lillard JW
Int J Cancer; 2009 Nov; 125(10):2288-95. PubMed ID: 19610059
[TBL] [Abstract][Full Text] [Related]
5. DOCK2 and phosphoinositide-3 kinase δ mediate two complementary signaling pathways for CXCR5-dependent B cell migration.
Wissmann S; Stolp B; Jímenez AM; Stein JV
Front Immunol; 2022; 13():982383. PubMed ID: 36341455
[TBL] [Abstract][Full Text] [Related]
6. Antibody Microarray Analysis of Signaling Networks Regulated by Cxcl13 and Cxcr5 in Prostate Cancer.
El-Haibi CP; Singh R; Gupta P; Sharma PK; Greenleaf KN; Singh S; Lillard JW
J Proteomics Bioinform; 2012; 5(8):177-184. PubMed ID: 24009409
[TBL] [Abstract][Full Text] [Related]
7. Serum CXCL13 positively correlates with prostatic disease, prostate-specific antigen and mediates prostate cancer cell invasion, integrin clustering and cell adhesion.
Singh S; Singh R; Sharma PK; Singh UP; Rai SN; Chung LW; Cooper CR; Novakovic KR; Grizzle WE; Lillard JW
Cancer Lett; 2009 Sep; 283(1):29-35. PubMed ID: 19375853
[TBL] [Abstract][Full Text] [Related]
8. CXC chemokine ligand-13 promotes metastasis via CXCR5-dependent signaling pathway in non-small cell lung cancer.
Chao CC; Lee WF; Wang SW; Chen PC; Yamamoto A; Chang TM; Weng SL; Liu JF
J Cell Mol Med; 2021 Oct; 25(19):9128-9140. PubMed ID: 34427969
[TBL] [Abstract][Full Text] [Related]
9. CXCL13-CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis.
Biswas S; Sengupta S; Roy Chowdhury S; Jana S; Mandal G; Mandal PK; Saha N; Malhotra V; Gupta A; Kuprash DV; Bhattacharyya A
Breast Cancer Res Treat; 2014 Jan; 143(2):265-76. PubMed ID: 24337540
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion.
Meng XN; Jin Y; Yu Y; Bai J; Liu GY; Zhu J; Zhao YZ; Wang Z; Chen F; Lee KY; Fu SB
Br J Cancer; 2009 Jul; 101(2):327-34. PubMed ID: 19568240
[TBL] [Abstract][Full Text] [Related]
11. Alterations in the focal adhesion kinase/Src signal transduction pathway correlate with increased migratory capacity of prostate carcinoma cells.
Slack JK; Adams RB; Rovin JD; Bissonette EA; Stoker CE; Parsons JT
Oncogene; 2001 Mar; 20(10):1152-63. PubMed ID: 11313859
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-8 confers androgen-independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAK.
Lee LF; Louie MC; Desai SJ; Yang J; Chen HW; Evans CP; Kung HJ
Oncogene; 2004 Mar; 23(12):2197-205. PubMed ID: 14767470
[TBL] [Abstract][Full Text] [Related]
13. Yes-mediated phosphorylation of focal adhesion kinase at tyrosine 861 increases metastatic potential of prostate cancer cells.
Chatterji T; Varkaris AS; Parikh NU; Song JH; Cheng CJ; Schweppe RE; Alexander S; Davis JW; Troncoso P; Friedl P; Kuang J; Lin SH; Gallick GE
Oncotarget; 2015 Apr; 6(12):10175-94. PubMed ID: 25868388
[TBL] [Abstract][Full Text] [Related]
14. Transcriptome Network Analysis Identifies CXCL13-CXCR5 Signaling Modules in the Prostate Tumor Immune Microenvironment.
Ohandjo AQ; Liu Z; Dammer EB; Dill CD; Griffen TL; Carey KM; Hinton DE; Meller R; Lillard JW
Sci Rep; 2019 Oct; 9(1):14963. PubMed ID: 31628349
[TBL] [Abstract][Full Text] [Related]
15. Phosphoinositide 3-kinase pathway activation in phosphate and tensin homolog (PTEN)-deficient prostate cancer cells is independent of receptor tyrosine kinases and mediated by the p110beta and p110delta catalytic subunits.
Jiang X; Chen S; Asara JM; Balk SP
J Biol Chem; 2010 May; 285(20):14980-14989. PubMed ID: 20231295
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic insights of epithelial protein lost in neoplasm in prostate cancer metastasis.
Collins RJ; Morgan LD; Owen S; Ruge F; Jiang WG; Sanders AJ
Int J Cancer; 2018 Nov; 143(10):2537-2550. PubMed ID: 30098000
[TBL] [Abstract][Full Text] [Related]
17. c-Src, Insulin-Like Growth Factor I Receptor, G-Protein-Coupled Receptor Kinases and Focal Adhesion Kinase are Enriched Into Prostate Cancer Cell Exosomes.
DeRita RM; Zerlanko B; Singh A; Lu H; Iozzo RV; Benovic JL; Languino LR
J Cell Biochem; 2017 Jan; 118(1):66-73. PubMed ID: 27232975
[TBL] [Abstract][Full Text] [Related]
18. CXCL13/CXCR5 Interaction Facilitates VCAM-1-Dependent Migration in Human Osteosarcoma.
Liu JF; Lee CW; Lin CY; Chao CC; Chang TM; Han CK; Huang YL; Fong YC; Tang CH
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32847038
[TBL] [Abstract][Full Text] [Related]
19. Exosome carrying PSGR promotes stemness and epithelial-mesenchymal transition of low aggressive prostate cancer cells.
Li Y; Li Q; Li D; Gu J; Qian D; Qin X; Chen Y
Life Sci; 2021 Jan; 264():118638. PubMed ID: 33164833
[TBL] [Abstract][Full Text] [Related]
20. CXCL13-CXCR5 axis promotes the growth and invasion of colon cancer cells via PI3K/AKT pathway.
Zhu Z; Zhang X; Guo H; Fu L; Pan G; Sun Y
Mol Cell Biochem; 2015 Feb; 400(1-2):287-95. PubMed ID: 25476740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
